Cefdinir - Oral products
Recognized Interpretive Criteria
Additional FDA-Identified Interpretive Criteria
|
Minimum Inhibitory |
Disk Diffusion |
||||
---|---|---|---|---|---|---|
Pathogen |
S |
I |
R |
S |
I |
R |
Haemophilus influenza |
M100 standard is recognized |
|||||
Streptococcus pneumoniae |
M100 standard is recognized |
- |
- |
- |
||
Streptococcus spp β- |
≤ 1 |
2 |
≥ 4 |
≥ 20 |
17 - 19 |
≤ 16 |
Moraxella catarrhalis |
≤ 1 |
2 |
≥ 4 |
≥ 20 |
17 - 19 |
≤ 16 |
S = Susceptible; I = Intermediate; R = Resistant
Exception to the recognized standard of CLSI M100
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Enterobacterales